Evidence map›Paper›PMID 41197791›Full record

ReviewAnaerobe2025

Milestones in Clostridium perfringens research since 1995.

Bruce A McClane, Jihong Li, Francisco A Uzal, Julian I Rood

Abstract readReviewHistorical Article
In one paragraph

Review in Anaerobe, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bruce A McClaneDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15219, USA. Electronic address: bamcc@pitt.edu.
Jihong LiDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15219, USA.
Francisco A UzalCalifornia Health and Food Safety Laboratory, School of Veterinary Medicine, University of California Davis, San Bernardino, CA, 92408, USA.
Julian I RoodInfection Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Vic, 3800, Australia.

Funding

MECHANISMS OF ACTION OF C PERFRINGENS EXTEROTOXINR01AI019844 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MC CLANE, BRUCE A · 1985 to 2024
$5.4M
Evaluating the role of branched chain amino acid transporters in Clostridium perfringens-induced gas gangrene in diabetic and normal mouse modelsR21AI178207 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LI, JIHONG, MC CLANE, BRUCE A · 2023 to 2024
$427k
NIAID NIH HHS R01 AI019844NIAID NIH HHS R21 AI178207
6 · The paper itself

Abstract

Clostridium perfringens is an important human and veterinary pathogen, as well as a common member of the normal intestinal microbiota. By applying molecular approaches, substantial progress has been achieved since 1995 in understanding the pathogenicity and biology of this gram-positive, anaerobic, spore-forming bacterium. For example, there is now a much improved understanding of the structure and action of its "legacy" toxins (i.e., CPA, PFO, ETX, CPB, ITX and CPE) and the pathogenic importance of many of those toxins has now been clearly demonstrated. In addition, several new toxins have been discovered since 1995 and at least one of those new toxins (NetB) has been clearly linked to disease. The importance and diversity of mobile genetic elements, particularly conjugative plasmids, for pathogenicity and antibiotic resistance is now established. Several regulators controlling virulence gene expression have been identified and, in some cases, their regulatory mechanisms have been clarified. For some regulators, their importance for virulence has also been demonstrated. Lastly, there is also improved knowledge of sporulation and germination mechanisms for C. perfringens, as well as how sporulation contributes to disease transmission and pathogenesis for this bacterium. Despite these advances, some important questions about C. perfringens remain to be explored.

Indexed as

Clostridium InfectionsClostridium perfringensAnimalsBacterial ToxinsGene Expression Regulation, BacterialHistory, 20th CenturyHumansSpores, BacterialVirulenceVirulence FactorsBacterial ToxinsVirulence Factors

Identifiers

PMID41197791
PMCPMC12828898

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.